{"schema_version":"secwatch.filing_event.v1","accession":"0001826667-25-000103","form_type":"8-K","ticker":"TLSI","cik":"0001826667","company_name":"TriSalus Life Sciences, Inc.","filed_at":"2025-07-24T23:59:59+00:00","discovered_at":"2026-05-14T18:02:45.170830+00:00","generated_at":"2026-05-18T02:32:27.645951+00:00","sec_items":["3.03","5.03","5.07","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"TriSalus completes Preferred Stock exchange; 98.82% tendered at 3.3 common shares each","bullets":["Approximately 98.82% of outstanding Series A Convertible Preferred Stock (3,551,502 shares) validly tendered in exchange offer.","Each preferred share exchanged for 3.3 shares of common stock, based on a $4.00 per common share conversion price.","Amendment to Certificate of Designations filed July 24, 2025, enabling mandatory conversion of remaining preferred shares.","Settlement of all validly tendered shares expected on or before August 1, 2025."],"urls":{"canonical":"https://secwatch.observer/filing/0001826667-25-000103","json":"https://secwatch.observer/filing/0001826667-25-000103.json","markdown":"https://secwatch.observer/filing/0001826667-25-000103.md","text":"https://secwatch.observer/filing/0001826667-25-000103.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1826667/000182666725000103/0001826667-25-000103-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1826667/000182666725000103/tlsi-20250724.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-18T02:32:27.645951+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"cd9e66128ef576d5eed80f9591646f61d56fa2e4","claim":"TriSalus Life Sciences, Inc.: Amended Certificate of Designations for Series A Convertible Preferred Stock to permit mandatory conversion upon closing of the exchange offer (effective 2025-07-24).","evidence_excerpt":"on July 24, 2025, the Company filed the Preferred Stock Amendment with the Secretary of State of the State of Delaware. The Preferred Stock Amendment will permit the Company to require that all shares of Preferred Stock that are outstanding upon the closing of the Offer be converted into the number of shares of Common Stock equal to the quotient of (i) the sum of (a) the Liquidation Preference (as defined in the Certificate of Designations (defined below)) and (b) the Accrued Dividends (as defined in the Certificate of Designations) if not otherwise paid by the Company, that would have accrued through closing the Offer (the “Exchanged Value”), divided by the Conversion Price (as defined in the Certificate of Designations, as such term will be amended by the Preferred Stock Amendment.","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1826667/000182666725000103/0001826667-25-000103-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"charter amendment"},{"label":"Effective","value":"2025-07-24"}],"fact_type":"governance_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}